NOWOGEN TECHNOLOGY PLACES MSEK 1.3 ORDER FOR SERIAL PRODUCTION OF FLOW
PLATES

Cell Impact AB (Nasdaq First North GM: CI B) has received an order
worth MSEK 1.3 for serial production of bipolar flow plates from Beijing-based
Nowogen Technology in China. The order is a continuation of the prototype order
that Nowogen placed in September last year.

This is the first order for serial
production of flow plates based on Nowogens flow plate design.

For more
information, please contact:

Mr. Pär Teike, CEO, +46 73-024 06 84 or
paer.teike@cellimpact.com mailto:paer.teike@cellimpact.com .

The following
documents can be retrieved from beQuoted
Cell Impact PressRelease EN
20210315.pdf-http://www.bequoted.com/beQPress/download.asp?Id=41911

About Cell
Impact

Cell Impact AB (publ) is a global supplier of advanced flow plates to
fuel cell manufacturers. The company has developed and patented a unique method
for high-velocity forming, Cell Impact Forming(tm), which makes it possible to
produce flow plates with more advanced designs, which in turn creates more cost
and energy-efficient fuel cells compared to conventional forming methods.

The
Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden
AB is the companys Certified Advisor (CA). Contact info: +46 8-528 00 399 or
info@fnca.se mailto:info@fnca.se .

This information is information that Cell
Impact AB (publ) is obliged to make public pursuant to the EU Market Abuse
Regulation.